Volume | 1,283,031 |
|
|||||
News | - | ||||||
Day High | 1.545 | Low High |
|||||
Day Low | 1.4217 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
SELLAS Life Sciences Group Inc | SLS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.53 | 1.4217 | 1.545 | 1.46 | 1.52 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
2,850 | 1,283,031 | $ 1.47 | $ 1,888,401 | - | 0.4986 - 1.914 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
17:18:51 | 1 | $ 1.4696 | USD |
SELLAS Life Sciences Group Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
46.49M | 32.06M | - | 0 | -37.34M | -1.16 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
SELLAS Life Sciences News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SLS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.54 | 1.72 | 1.4217 | 1.56 | 1,469,688 | -0.10 | -6.49% |
1 Month | 1.03 | 1.72 | 0.975 | 1.39 | 1,462,009 | 0.41 | 39.81% |
3 Months | 0.5848 | 1.72 | 0.5595 | 1.16 | 1,400,092 | 0.8552 | 146.24% |
6 Months | 0.90 | 1.72 | 0.4986 | 1.00 | 1,188,765 | 0.54 | 60.00% |
1 Year | 1.40 | 1.914 | 0.4986 | 1.07 | 710,536 | 0.04 | 2.86% |
3 Years | 8.24 | 15.0789 | 0.4986 | 3.18 | 430,333 | -6.80 | -82.52% |
5 Years | 0.92 | 19.38 | 0.11 | 1.97 | 2,402,048 | 0.52 | 56.52% |
SELLAS Life Sciences Description
SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax. |